IP Library Assignment 055301/0444
Patent Assignment
Reel/Frame 055301/0444

Change of Name

Recorded: 2021-02-13 Pages: 3
Assignor
NEURON SYSTEMS, INC.
Executed: 2012-12-20
Assignee
ALDEXA THERAPEUTICS, INC.
15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON, MASSACHUSETTS, 01803
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Application: 17/164,556 →
Publication: US 2021/0269402
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Address Feb 13, 2021
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 056110/0450 →
Assignment of Assignor's Interest Feb 13, 2021
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 055251/0541 →
Change of Name Feb 13, 2021
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 055301/0457 →